Your search returned 5 results.

Results
	1.	Metabolic syndrome and its single traits as risk factors for diabetes in people with impaired glucose tolerance: the STOP-NIDDM trial. [electronic resource] by Hanefeld, Markolf Karasik, Avraham Koehler, Carsta Westermeier, Torsten Chiasson, Jean-Louis Producer: 20090515 In: Diabetes & vascular disease research vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Long-term improvement of metabolic control by acarbose in type 2 diabetes patients poorly controlled with maximum sulfonylurea therapy. [electronic resource] by Bachmann, Werner Petzinna, Dieter Raptis, Sotirios A Wascher, Thomas Westermeier, Torsten Producer: 20121002 In: Clinical drug investigation vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Development and validation of a risk-score model for subjects with impaired glucose tolerance for the assessment of the risk of type 2 diabetes mellitus-The STOP-NIDDM risk-score. [electronic resource] by Tuomilehto, Jaakko Lindström, Jaana Hellmich, Martin Lehmacher, Walter Westermeier, Torsten Evers, Thomas Brückner, Andreas Peltonen, Markku Qiao, Qing Chiasson, Jean-Louis Producer: 20100423 In: Diabetes research and clinical practice vol. 87 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies. [electronic resource] by Turpie, Alexander G G Lassen, Michael Rud Eriksson, Bengt I Gent, Michael Berkowitz, Scott D Misselwitz, Frank Bandel, Tiemo J Homering, Martin Westermeier, Torsten Kakkar, Ajay K Producer: 20110621 In: Thrombosis and haemostasis vol. 105 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Rivaroxaban: a novel oral anticoagulant for the prevention and treatment of several thrombosis-mediated conditions. [electronic resource] by Sarich, Troy C Peters, Gary Berkowitz, Scott D Misselwitz, Frank Nessel, Christopher C Burton, Paul Cook-Bruns, Nancy Lensing, Anthonie W A Haskell, Lloyd Perzborn, Elisabeth Kubitza, Dagmar Moore, Kenneth T Jalota, Sanjay Weber, Juergen Pan, Guohua Sun, Xiang Westermeier, Torsten Nadel, Andrea Oppenheimer, Leonard DiBattiste, Peter M Producer: 20131025 In: Annals of the New York Academy of Sciences vol. 1291 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)